Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Millipore acquires Serologicals

May 1, 2006 | A version of this story appeared in Volume 84, Issue 18

Bioscience products and services firm Millipore will acquire Serologicals, a specialist in drug discovery equipment and services, for approximately $1.4 billion. Millipore says the acquisition will strengthen its position in areas such as antibodies, cell biology reagents, and stem cell research in drug discovery. "Serologicals and Millipore are two of the fastest growing companies in our sector, and our combination will create a company with very attractive growth and profitability," Millipore CEO Martin Madaus says.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.